Maastricht University Library celebrates International Open Access Week 2021
Open Access is an essential pillar of UM’s Open Science policy. Throughout the year, the University Library works to promote Open Access at Maastricht University actively. Not only by providing information and support but also by entering into agreements with publishers to reduce publishing costs and supporting alternative ways to Open Access and share research output. But because this week is International Open Access Week, we celebrate this with extra attention to new developments, services and tips.
During International Open Access Week, 25-31 October, we will launch the new and improved Open Access Journal Browser, the primary tool for our scholars to find out about OA publishing discounts and OA sharing options. Also, the first edition of the FAIR for Qualitative Data will take place. And, together with all Dutch universities, we will present A Practical Guide to Preprints to help accelerate scholarly communication.
We will also bust a couple of Open Access Myths, and you are welcome to visit two Open Access Drop-In Sessions to talk about publishing issues. And we will close Open Access Week 2021 with a special OA issue of our Library+ Research update.
More information via UM Library
Relevant links
Also read
-
The Association of Universities in the Netherlands (VSNU), the Dutch Federation of University Medical Centers (NFU), the Netherlands Organization for Scientific Research (NWO) and Elsevier announced that they have entered into a national agreement. Maastricht University and MUMC+ participate in this...
-
VSNU, NFU, NWO and Elsevier have reached a framework agreement. In the short term, this means that from January 2020 we will have access to all online journals from Elsevier and UM scholars can publish Open Access in all Elsevier journals – Full OA and Hybrid – without paying APC.
-
Maastricht University and MUMC+ students and staff can access the articles of the Royal Society of Chemistry (RSC) journals again. The current subscription runs until 2021.
